These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 30830309)
1. Malondialdehyde and advanced oxidation protein products are not increased in psoriasis: a controlled study. Skoie IM; Dalen I; Omdal R; Jonsson G Arch Dermatol Res; 2019 May; 311(4):299-308. PubMed ID: 30830309 [TBL] [Abstract][Full Text] [Related]
2. Advanced oxidation protein products and malondialdehyde - the new biological markers of oxidative stress - are elevated in postmenopausal women. Cakir T; Goktas B; Mutlu MF; Mutlu I; Bilgihan A; Erdem M; Erdem A Ginekol Pol; 2016; 87(5):321-5. PubMed ID: 27304645 [TBL] [Abstract][Full Text] [Related]
3. [Correlation between the serum level of advanced oxidation protein products and the cognitive function in patients with obstructive sleep apnea hypopnea syndrome]. Yang XH; Liu X; Shang J; Liu HG; Xu YJ Zhonghua Jie He He Hu Xi Za Zhi; 2013 Apr; 36(4):274-9. PubMed ID: 23945341 [TBL] [Abstract][Full Text] [Related]
4. A novel approach in psoriasis: first usage of known protein oxidation markers to prove oxidative stress. Yazici C; Köse K; Utaş S; Tanrikulu E; Taşlidere N Arch Dermatol Res; 2016 Apr; 308(3):207-12. PubMed ID: 26842230 [TBL] [Abstract][Full Text] [Related]
5. Investigation on malondialdehyde, S100B, and advanced oxidation protein product levels in significant hyperbilirubinemia and the effect of intensive phototherapy on these parameters. Sarici D; Gunes T; Yazici C; Akin MA; Korkmaz L; Memur S; Kurtoglu S; Ozturk MA; Sarici SU Pediatr Neonatol; 2015 Apr; 56(2):95-100. PubMed ID: 25261050 [TBL] [Abstract][Full Text] [Related]
6. Salivary Antioxidants and Oxidative Stress in Psoriatic Patients: Can Salivary Total Oxidant Status and Oxidative Status Index Be a Plaque Psoriasis Biomarker? Skutnik-Radziszewska A; Maciejczyk M; Fejfer K; Krahel J; Flisiak I; Kołodziej U; Zalewska A Oxid Med Cell Longev; 2020; 2020():9086024. PubMed ID: 31998446 [TBL] [Abstract][Full Text] [Related]
7. Systemic redox biomarkers and their relationship to prognostic risk markers in autosomal dominant polycystic kidney disease and IgA nephropathy. Tariq A; Mansoor MA; Marti HP; Jonsson G; Slettan A; Weeraman P; Apeland T Clin Biochem; 2018 Jun; 56():33-40. PubMed ID: 29655960 [TBL] [Abstract][Full Text] [Related]
8. Plasma levels of oxidative stress in children with steroid-sensitive nephrotic syndrome and their predictive value for relapse frequency. Fan A; Jiang X; Mo Y; Tan H; Jiang M; Li J Pediatr Nephrol; 2016 Jan; 31(1):83-8. PubMed ID: 26341250 [TBL] [Abstract][Full Text] [Related]
9. Correlation of TGF-β1 and oxidative stress in the blood of patients with melanoma: a clue to understanding melanoma progression? Santos Bernardes S; de Souza-Neto FP; Pasqual Melo G; Guarnier FA; Marinello PC; Cecchini R; Cecchini AL Tumour Biol; 2016 Aug; 37(8):10753-61. PubMed ID: 26873487 [TBL] [Abstract][Full Text] [Related]
10. Increased plasma levels of advanced oxidation protein products (AOPP) as a marker for oxidative stress in patients with active ulcerative colitis. Alagozlu H; Gorgul A; Bilgihan A; Tuncer C; Unal S Clin Res Hepatol Gastroenterol; 2013 Feb; 37(1):80-5. PubMed ID: 22572519 [TBL] [Abstract][Full Text] [Related]
11. An investigation into the serum thioredoxin, superoxide dismutase, malondialdehyde, and advanced oxidation protein products in patients with breast cancer. Kilic N; Yavuz Taslipinar M; Guney Y; Tekin E; Onuk E Ann Surg Oncol; 2014 Dec; 21(13):4139-43. PubMed ID: 24962940 [TBL] [Abstract][Full Text] [Related]
12. Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis. Baskol G; Demir H; Baskol M; Kilic E; Ates F; Karakukcu C; Ustdal M Cell Biochem Funct; 2006; 24(4):307-11. PubMed ID: 16142689 [TBL] [Abstract][Full Text] [Related]
13. High predictive ability of glycated hemoglobin on comparison with oxidative stress markers in assessment of chronic vascular complications in type 2 diabetes mellitus. D'Souza JM; D'Souza RP; Vijin VF; Shetty A; Arunachalam C; Pai VR; Shetty R; Faarisa A Scand J Clin Lab Invest; 2016; 76(1):51-7. PubMed ID: 26494020 [TBL] [Abstract][Full Text] [Related]
14. Predictive value of oxidative stress biomarkers in drug‑free patients with schizophrenia and schizo-affective disorder. Guidara W; Messedi M; Naifar M; Maalej M; Grayaa S; Omri S; Ben Thabet J; Maalej M; Charfi N; Ayadi F Psychiatry Res; 2020 Nov; 293():113467. PubMed ID: 33198042 [TBL] [Abstract][Full Text] [Related]
15. Elevated plasma dityrosine in patients with hyperlipidemia compared to healthy individuals. Wu GR; Cheserek M; Shi YH; Shen LY; Yu J; Le GW Ann Nutr Metab; 2015; 66(1):44-50. PubMed ID: 25531053 [TBL] [Abstract][Full Text] [Related]
16. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients. Brzović-Šarić V; Landeka I; Šarić B; Barberić M; Andrijašević L; Cerovski B; Oršolić N; Đikić D Mol Vis; 2015; 21():649-64. PubMed ID: 26120270 [TBL] [Abstract][Full Text] [Related]
17. Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation. Venturini D; Simão AN; Dichi I Nutr Res; 2015 Sep; 35(9):759-65. PubMed ID: 26255193 [TBL] [Abstract][Full Text] [Related]
18. [Increased levels of advanced oxidation protein products are associated with atherosclerosis in chronic kidney disease]. Yang XB; Hou FF; Wu Q; Zhou H; Liu ZR; Yang Y; Zhang X Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):342-6. PubMed ID: 16009002 [TBL] [Abstract][Full Text] [Related]
19. Increased IL-1β levels are associated with an imbalance of "oxidant/antioxidant" status during Behçet's disease. Chekaoui A; Lahmar K; Belguendouz H; Mazari F; Terahi M; Hakem D; Youinou P; Touil-Boukoffa C Eur Cytokine Netw; 2018 Sep; 29(3):95-102. PubMed ID: 30547891 [TBL] [Abstract][Full Text] [Related]
20. Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients. Zhou Q; Wu S; Jiang J; Tian J; Chen J; Yu X; Chen P; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Xie DI; Liu J; Xu X; Liang M; Hou F Nephrology (Carlton); 2012 Sep; 17(7):642-9. PubMed ID: 22738256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]